1. Home
  2. EFT vs ETON Comparison

EFT vs ETON Comparison

Compare EFT & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFT
  • ETON
  • Stock Information
  • Founded
  • EFT 2004
  • ETON 2017
  • Country
  • EFT United States
  • ETON United States
  • Employees
  • EFT N/A
  • ETON N/A
  • Industry
  • EFT Finance Companies
  • ETON Biotechnology: Pharmaceutical Preparations
  • Sector
  • EFT Finance
  • ETON Health Care
  • Exchange
  • EFT Nasdaq
  • ETON Nasdaq
  • Market Cap
  • EFT 349.9M
  • ETON 329.8M
  • IPO Year
  • EFT N/A
  • ETON 2018
  • Fundamental
  • Price
  • EFT $13.32
  • ETON $13.57
  • Analyst Decision
  • EFT
  • ETON Strong Buy
  • Analyst Count
  • EFT 0
  • ETON 2
  • Target Price
  • EFT N/A
  • ETON $15.00
  • AVG Volume (30 Days)
  • EFT 100.8K
  • ETON 182.6K
  • Earning Date
  • EFT 01-01-0001
  • ETON 11-12-2024
  • Dividend Yield
  • EFT 10.63%
  • ETON N/A
  • EPS Growth
  • EFT N/A
  • ETON N/A
  • EPS
  • EFT 1.73
  • ETON N/A
  • Revenue
  • EFT N/A
  • ETON $34,677,000.00
  • Revenue This Year
  • EFT N/A
  • ETON $22.25
  • Revenue Next Year
  • EFT N/A
  • ETON $80.27
  • P/E Ratio
  • EFT $7.62
  • ETON N/A
  • Revenue Growth
  • EFT N/A
  • ETON 5.64
  • 52 Week Low
  • EFT $11.10
  • ETON $3.03
  • 52 Week High
  • EFT $13.44
  • ETON $13.98
  • Technical
  • Relative Strength Index (RSI)
  • EFT 46.82
  • ETON 67.80
  • Support Level
  • EFT $13.15
  • ETON $12.00
  • Resistance Level
  • EFT $13.53
  • ETON $13.29
  • Average True Range (ATR)
  • EFT 0.15
  • ETON 0.75
  • MACD
  • EFT -0.02
  • ETON -0.05
  • Stochastic Oscillator
  • EFT 42.50
  • ETON 99.48

About EFT Eaton Vance Floating Rate Income Trust of Beneficial Interest

Eaton Vance Floating-rate Income Trust is a closed-end management investment company. The company's objective is to provide a high level of current income and its secondary objective is capital appreciation.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Share on Social Networks: